Get started
Work

Abstract PS2-08-10: Peripheral immune profiling during neoadjuvant HER2-targeted therapy in HER2-positive (HER2+) early breast cancer (EBC): Mass cytometry (CyTOF) analysis from the MARGOT trial

Year: 2026
Type: conference-abstract
DOI: 10.1158/1557-3265.sabcs25-ps2-08-10
Authors: E. Segui, H. Heiling, J. Baginska, A. N. Nau, I. Gomez Diaz, J. Huezo, P. R. Pohlmann, M. F. Rimawi, N. F. Sinclair, R. L. Yung, N. U. Lin, A. C. Wolff, M. K. DeMeo, A. Root, T. Rahman, A. Mohammed-Abreu, M. DiLullo, A. Patel, E. R. Ogayo, T. A. King, E. P. Winer, E. A. Mittendorf, N. Tayob, S. Tolaney, I. E. Krop, J. Agudo, A. G. Waks
Institutions: Dana-Farber Cancer Institute, Baylor College of Medicine, Dana-Farber Brigham Cancer Center, Fred Hutch Cancer Center, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, Drexel University, Yale Cancer Center, Yale University
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W7130713218
Cites:
Cited by: 1
Related to: